News
ILMNV
107.25
0.00%
0.00
ILLUMINA <ILMN.O>: BARCLAYS RAISES TARGET PRICE TO $145 FROM $122
Reuters · 14h ago
Illumina director Daniel Skovronsky files initial beneficial ownership statement
PUBT · 1d ago
Illumina appoints Lilly R&D chief Skovronsky to board
PUBT · 1d ago
DANIEL M. SKOVRONSKY, MD, PHD, APPOINTED TO ILLUMINA'S BOARD OF DIRECTORS
Reuters · 1d ago
U.S. RESEARCH ROUNDUP- Datadog, Jabil, Prologis
Reuters · 6d ago
ILLUMINA INC <ILMN.O>: JEFFERIES RAISES TARGET PRICE TO $150 FROM $125
Reuters · 6d ago
BUZZ-U.S. STOCKS ON THE MOVE-Illumina, Cullinan, BorgWarner
Reuters · 06/10 15:40
BUZZ-Illumina rises after J.P. Morgan upgrades to 'overweight'
Reuters · 06/10 13:48
ILLUMINA INC <ILMN.O>: JP MORGAN RAISES TO OVERWEIGHT FROM NEUTRAL; RAISES TARGET PRICE TO $185 FROM $125
Reuters · 06/10 09:34
U.S. RESEARCH ROUNDUP- Datadog, Eli Lilly, Oracle
Reuters · 06/10 07:48
Samsung Electronics invests $175 million in Element Biosciences' Series E funding round
Reuters · 06/09 16:23
ILLUMINA LAUNCHES STRATAMAP SPATIAL SOLUTION, A POWERFUL END-TO-END SPATIAL WHOLE TRANSCRIPTOME RESEARCH SOLUTION
Reuters · 06/08 13:15
Illumina director Keith Meister reports disposal of shares worth $89.69 million
PUBT · 06/01 22:05
Illumina Chief Legal Officer Scott M. Davies sells 615 shares worth $98,400
PUBT · 06/01 20:33
Illumina teams with IDT to offer DRAGEN-powered secondary analysis for oncology sequencing workflows
PUBT · 06/01 12:58
ILLUMINA INC <ILMN.O>: GUGGENHEIM RAISES TARGET PRICE TO $180 FROM $170
Reuters · 06/01 10:12
U.S. RESEARCH ROUNDUP-Palomar Holdings, Replimune Group, Snowflake
Reuters · 06/01 07:39
Illumina, SPT Labtech launch fireflyGO automation platform for targeted oncology sequencing workflows
PUBT · 05/28 16:31
ILLUMINA AND SPT LABTECH UNVEIL FIREFLYGO, ENABLING FASTER, SIMPLER TARGETED ONCOLOGY RESEARCH
Reuters · 05/28 16:30
ILLUMINA INTRODUCES THE FIRST DISTRIBUTED WHOLE-GENOME SEQUENCING SOLUTION FOR HIGHLY SENSITIVE MRD RESEARCH
Reuters · 05/28 13:15
More
Webull provides a variety of real-time ILMNV stock news. You can receive the latest news about Illumina Inc through multiple platforms. This information may help you make smarter investment decisions.
About ILMNV
Illumina, Inc. is engaged in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. The Company’s products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. Its product categories include Instruments, Kits & Reagents, Selection Tools, and Software & Analysis. Its Instruments category include sequencing platforms, microarray scanners, and IVD instruments. Its Kits & Reagents category consists of library preparation kits, sequencing reagents, microarray kits, clinical research products, and IVD products. Its Selection Tools category include Library Prep & Array Kit Selector, Gene Panel & Array Finder, DesignStudio Custom Assay Designer, and other. Its services include sequencing services, microarray services, proactive instrument monitoring, and instrument services and training. Its customers include academic institutions, government laboratories, and others.